Larimar Therapeutics Common Stock

Larimar Therapeutics (LRMR) currently reports a common stock of $100K as of June 2026. That compares with $64K in the prior-year period — up 60.9% year over year. Use the charts on this page to explore Larimar Therapeutics's common stock history and peer comparisons.

Larimar Therapeutics's common stock increased from $64K to $100K — a 60.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Larimar Therapeutics reported $100K in common stock as of June 2026. That compares with $64K in the prior-year period — up 60.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $100K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Larimar Therapeutics, and consider following LRMR for alerts when major investors trade the stock.

Larimar Therapeutics is classified in the Healthcare sector. On common stock, it currently shows $100K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LRMR with unrelated industries.